DE69732350D1 - Persephin und verwandte wachstumsfaktoren - Google Patents

Persephin und verwandte wachstumsfaktoren

Info

Publication number
DE69732350D1
DE69732350D1 DE69732350T DE69732350T DE69732350D1 DE 69732350 D1 DE69732350 D1 DE 69732350D1 DE 69732350 T DE69732350 T DE 69732350T DE 69732350 T DE69732350 T DE 69732350T DE 69732350 D1 DE69732350 D1 DE 69732350D1
Authority
DE
Germany
Prior art keywords
persephin
methods
growth factors
mouse
neurturin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69732350T
Other languages
English (en)
Other versions
DE69732350T2 (de
Inventor
M Johnson
D Milbrandt
T Kotzbauer
A Lampe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Louis University
Washington University in St Louis WUSTL
Original Assignee
St Louis University
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Louis University, Washington University in St Louis WUSTL filed Critical St Louis University
Publication of DE69732350D1 publication Critical patent/DE69732350D1/de
Application granted granted Critical
Publication of DE69732350T2 publication Critical patent/DE69732350T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DE69732350T 1996-03-14 1997-03-14 Persephin und verwandte wachstumsfaktoren Expired - Lifetime DE69732350T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61594496A 1996-03-14 1996-03-14
US615944 1996-03-14
PCT/US1997/003461 WO1997033911A1 (en) 1996-03-14 1997-03-14 Persephin and related growth factors

Publications (2)

Publication Number Publication Date
DE69732350D1 true DE69732350D1 (de) 2005-03-03
DE69732350T2 DE69732350T2 (de) 2005-12-22

Family

ID=24467424

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69732350T Expired - Lifetime DE69732350T2 (de) 1996-03-14 1997-03-14 Persephin und verwandte wachstumsfaktoren

Country Status (10)

Country Link
US (4) US6692943B1 (de)
EP (1) EP0886651B1 (de)
JP (1) JP2000507813A (de)
AT (1) ATE287953T1 (de)
AU (1) AU716846B2 (de)
CA (1) CA2225913A1 (de)
DE (1) DE69732350T2 (de)
ES (1) ES2237793T3 (de)
NZ (1) NZ329482A (de)
WO (1) WO1997033911A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739307A (en) * 1995-08-28 1998-04-14 Washington University Polynucleotide encoding neurturin neurotrophic factor
US7015316B1 (en) * 1996-03-14 2006-03-21 Washington University Polynucleotides encoding human persephin and related growth factors
WO1997033911A1 (en) * 1996-03-14 1997-09-18 Washington University Persephin and related growth factors
US6222022B1 (en) * 1996-03-14 2001-04-24 Washington University Persephin and related growth factors
DE19816186A1 (de) * 1998-04-14 1999-10-21 Univ Muenchen L Maximilians GDNF-kodierende DNA, Teile davon und GDNF-Varianten
AU5244199A (en) * 1998-07-31 2000-02-21 Genentech Inc. Persephin arf, a protein encoded by unspliced persephin mrna
EE200100103A (et) * 1998-08-21 2002-06-17 Sariola Hannu Gliiarakuliinist pärineva neurotroofse faktori perekonnaga seotud ühendite kasutamine spermatogeneesi reguleerimiseks ja isastel kasutatavate kontratseptiivide valmistamiseks
US20020002269A1 (en) * 1998-09-29 2002-01-03 Jeffrey D. Milbrandt Artemin, a neurotrophic factor
FI991197A0 (fi) * 1999-05-27 1999-05-27 Mart Saarma Neurotrooppiset tekijät lantionalueen ääreishermoston toimintahäiriön hoitamisessa
US6866851B1 (en) * 1999-12-28 2005-03-15 Washington University GFRα1-RET specific agonists and methods therefor
FI20000403A0 (fi) * 2000-02-22 2000-02-22 Hannu Sariola GDNF perhesukuisten yhdisteiden käyttö kivessyövän hoitoon tarkoitettujen tuotteiden valmistamiseksi
WO2010144696A1 (en) 2009-06-11 2010-12-16 Burnham Institute For Medical Research Directed differentiation of stem cells
US9821026B2 (en) * 2012-06-28 2017-11-21 Instituto De Medicina Molecular Use of RET agonist molecules for haematopoietic stem cell expansion protocols and transplantation therapy and a RET agonist kit

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011914A (en) 1989-01-05 1991-04-30 Collins Franklin D Purified ciliary neurotrophic factor
US5141856A (en) * 1989-01-05 1992-08-25 Synergen, Inc. Expression of purified ciliary neurotrophic factor
US5260417A (en) * 1989-04-03 1993-11-09 Genetics Institute, Inc. Megakaryocyte growth promoting activity protein
US5235043A (en) 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
CA2119463C (en) 1991-09-20 2003-09-16 Leu-Fen H. Lin Glial cell line-derived neutrophic factor
CA2170751A1 (en) 1993-09-01 1995-03-09 Timothy J. Cunningham Neuron regulatory factor for promoting neuron survival
WO1995017203A1 (en) 1993-12-22 1995-06-29 The University Of Medicine And Dentistry Of New Jersey Novel nucleic acid sequences isolated from glial cells
US5739307A (en) 1995-08-28 1998-04-14 Washington University Polynucleotide encoding neurturin neurotrophic factor
WO1997033911A1 (en) * 1996-03-14 1997-09-18 Washington University Persephin and related growth factors

Also Published As

Publication number Publication date
US6692943B1 (en) 2004-02-17
US6403335B1 (en) 2002-06-11
AU716846B2 (en) 2000-03-09
EP0886651A4 (de) 2001-01-10
NZ329482A (en) 2000-05-26
DE69732350T2 (de) 2005-12-22
US6232449B1 (en) 2001-05-15
US6645937B1 (en) 2003-11-11
WO1997033911A1 (en) 1997-09-18
ATE287953T1 (de) 2005-02-15
CA2225913A1 (en) 1997-09-18
ES2237793T3 (es) 2005-08-01
EP0886651B1 (de) 2005-01-26
JP2000507813A (ja) 2000-06-27
AU2580497A (en) 1997-10-01
EP0886651A1 (de) 1998-12-30

Similar Documents

Publication Publication Date Title
ATE315578T1 (de) Neuriturin und verwandte wachstumsfaktoren
DE69732350D1 (de) Persephin und verwandte wachstumsfaktoren
ATE288447T1 (de) Methode zur behandlung von alzheimer mit einem von einer gliazelllinie stammenden neurotrophen protein (gdnf)
DE69833211D1 (de) Humanes persephin
AU3472997A (en) Ret ligand (retl) for stimulating neural and renal growth
ATE256475T1 (de) Verwendung von follistatin zur herstellung eines arzneimittels zur behandlung von muskuläre krankheiten
KR920700291A (ko) 골 유도 조성물
DE69840403D1 (de) System zum transfer und zur expression von heterologen genen ins knochenmark in vivo
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
AU1615599A (en) Differentiation of adipose stromal cells into osteoblasts and uses thereof
LV10308A (lv) Ciliarais neirotropais faktors
ATE267247T1 (de) Reagenz und verfahren zur inhibierung der n-ras expression
DE69940206D1 (de) Verfahren zur behandlung von multiplem myelom und von myelom- induzierter knochenresorption mit antagonisten der integrin-/rezeptorbindung
EE200100472A (et) Polüpeptiid, antikehad, lahustuv polüpeptiid, polü- või oligonukleotiid ja meetod diferentsiaalseltekspresseerunud DNA järjestuste spetsiifiliseks identifitseerimiseks
ATE203766T1 (de) Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose
Iimura et al. Changes in homeobox-containing gene expression during ectopic bone formation induced by bone morphogenetic protein
DK87190A (da) Fremgangsmaade til at regulere plantevaekst under anvendelse af svovlholdige organiske syrer
KR19990036081A (ko) 인간 엠피52 에이알지 단백질
RU2003123108A (ru) Мутантные формы человеческого белка fgf23, снижающие содержание фосфора в крови
Kotze et al. An exon 4 mutation identified in the majority of South African familial hypercholesterolaemics.
ATE227998T1 (de) Verwendung von substituierten dextranen zur behandlung von schädigungen des nervensystems, und fraktionen mit erhöhtem heparansulfat-gehalt
DE3687241T2 (de) Gewebetumorwachstumsinhibitoren, verfahren zur herstellung und verwendungen.
Wirtz et al. In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-terminal propeptides with mutant pN alpha 2 (I) collagen chains in native mutant collagen in a case of Ehlers-Danlos syndrome, type VII.
Espaillat et al. Expression of fibronectin isoforms in rat cornea after an epithelial-scrape wound
WO1999025721B1 (en) Detection and treatment of retinal degenerative disease

Legal Events

Date Code Title Description
8364 No opposition during term of opposition